Proving the Business Case for the Internet of Things

AlertWatch gains FDA approval for patient-monitoring software

Iain Morris
February 19, 2014

A startup backed by the University of Michigan says it has received clearance from the US Food and Drug Administration (FDA) to begin selling its patient-monitoring software to hospitals.

AlertWatch (Ann Arbor, MI, USA) – which says its goal is to help anesthesia providers monitor patients in the operating room – has developed software that aggregates data from physiological monitors, anesthesia records, lab results and medical history to produce a real-time display of a patient’s condition.

Its technology continually analyzes data and helps determine whether conditions are normal, marginal or abnormal through the used of colored icons.

“We’ve had a lot of interest from clinicians who have seen the demo,” said Justin Adams, the chief executive of AlertWatch. “Now that we’re over the FDA hurdle, it’ll be great to get the product into their hands.”

AlertWatch has run pilots at a number of universities and plans to begin installing its technology at a several large US hospitals in the near future.

“AlertWatch has made impressive progress in their regulatory requirements and is a great example of the digital health opportunities from the university,” said Ken Nisbet, associate vice president of the University of Michigan Tech Transfer.
 
Other News
 
Digi International supports remote-monitoring for rail operators
 
M2M player Digi International is to support the rollout of new asset-tracking services for rail systems by long-standing partner OEM Technology Solutions.

Catena to provide M2M service for cold chain transportation

Businessman Alberto Marzan has launched a new company called Catena whose professed goal is to “solve logistical pain points throughout the $90 billion cold chain transportation industry”.